Home LiteratureArticle Details
PMID: 1312610 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro.

Journal of virology ·Vol. 66 ·No. 4 ·1992-04-00 ·Pages 1899-906

Lee MA, Yates JL

Abstract

The Epstein-Barr virus (EBV) genome contains an open reading frame, BHRF1, that encodes a presumptive membrane protein with sequence similarity to the proto-oncogene bcl2, which is linked to human B-cell follicular lymphoma. Potential roles for BHRF1 in EBV's ability to growth transform human B cells and to replicate in B cells in culture were investigated by generating EBV mutants that lack most of the open reading frame. This was accomplished by recombination of plasmids carrying mutations in BHRF1 with the transformation-defective EBV strain P3HR1. Because BHRF1 resides close to the deletion in P3HR1 that renders this strain transformation defective, B-cell transformation could be used to select for recombination events in the region. B-cell clones were established by recombinants which lacked most of the BHRF1 open reading frame, although most of these initial B-cell transformants also carried nonrecombinant (BHRF1+) P3HR1 genomes, at levels ranging from a fraction of a copy to four copies per cell. Secondary B-cell transformants that lacked BHRF1+ EBV at detectable levels were found to release transforming, BHRF1-deficient EBV at levels that were within the normal range for EBV-immortalized B-cell clones. These studies demonstrate that BHRF1 is nonessential for growth transformation of B cells and for virus replication and release from these cells in culture.

Related Genes
MeSH Terms
B-Lymphocytes/microbiology Blotting, Southern Cell Transformation, Viral/genetics Cytomegalovirus/genetics Genetic Markers Genome, Viral Herpesvirus 4, Human/genetics,physiology Humans Open Reading Frames Proto-Oncogene Mas Proto-Oncogene Proteins/genetics Proto-Oncogene Proteins c-bcl-2 Recombination, Genetic Restriction Mapping Sequence Homology, Nucleic Acid Viral Envelope Proteins/genetics Virus Replication/genetics
Chemicals
Genetic Markers MAS1 protein, human Proto-Oncogene Mas Proto-Oncogene Proteins Proto-Oncogene Proteins c-bcl-2 Viral Envelope Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lee M A
Department of Human Genetics, Roswell Park Cancer Institute, Buffalo, New York 14263.
Yates J L
References (38)
38 references, click to expand
  1. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.
    Virology. 1979 Jun;95(2):351-8 PMID: 223286
  2. Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcript.
    J Virol. 1983 Oct;48(1):135-48 PMID: 6310141
  3. BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense.
    Proc Natl Acad Sci U S A. 1990 May;87(10):3660-4 PMID: 1692620
  4. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
    Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1546-50 PMID: 1847527
  5. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    J Virol. 1991 Apr;65(4):1701-9 PMID: 1848303
  6. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    J Virol. 1990 May;64(5):2309-18 PMID: 2157887
  7. Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population.
    Mol Cell Biol. 1990 May;10(5):1901-7 PMID: 2183011
  8. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Nature. 1990 Nov 22;348(6299):331-3 PMID: 2250704
  9. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
    Nature. 1990 Nov 22;348(6299):334-6 PMID: 2250705
  10. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    J Virol. 1990 Jul;64(7):3407-16 PMID: 2352328
  11. The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation.
    Oncogene. 1989 Jan;4(1):67-74 PMID: 2536919
  12. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    J Virol. 1989 Apr;63(4):1531-9 PMID: 2538644
  13. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.
    J Virol. 1989 Jun;63(6):2657-66 PMID: 2542579
  14. Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells.
    Proc Natl Acad Sci U S A. 1989 Jun;86(12):4589-93 PMID: 2543982
  15. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Nature. 1989 Aug 3;340(6232):393-7 PMID: 2547164
  16. Stress-resistance conferred by high level of bcl-2 alpha protein in human B lymphoblastoid cell.
    Oncogene. 1989 Nov;4(11):1331-6 PMID: 2554236
  17. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 PMID: 2556717
  18. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.
    Cell. 1989 Apr 7;57(1):79-88 PMID: 2649247
  19. Deregulated BCL2 expression enhances growth of a human B cell line.
    Oncogene. 1989 Sep;4(9):1123-7 PMID: 2789359
  20. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.
    Virology. 1987 Sep;160(1):151-61 PMID: 2820125
  21. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.
    J Virol. 1988 Jul;62(7):2274-84 PMID: 2836611
  22. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.
    J Virol. 1988 Jul;62(7):2337-46 PMID: 2836616
  23. Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes.
    Proc Natl Acad Sci U S A. 1988 Jun;85(11):3678-82 PMID: 2836854
  24. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.
    Cell. 1988 Nov 4;55(3):427-33 PMID: 2846181
  25. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.
    Cell. 1986 Oct 10;47(1):19-28 PMID: 2875799
  26. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.
    Mol Cell Biol. 1985 Feb;5(2):410-3 PMID: 2983194
  27. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
    Nature. 1985 Feb 28-Mar 6;313(6005):812-5 PMID: 2983224
  28. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.
    Proc Natl Acad Sci U S A. 1985 Jun;82(12):4085-9 PMID: 2987963
  29. Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components.
    J Virol. 1985 Aug;55(2):431-41 PMID: 2991567
  30. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.
    Cell. 1985 Dec;43(3 Pt 2):831-40 PMID: 3000618
  31. Epstein-Barr virus mRNAs produced by alternative splicing.
    Nucleic Acids Res. 1986 Sep 11;14(17):7103-14 PMID: 3020506
  32. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6 PMID: 3033649
  33. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Nature. 1988 Sep 29;335(6189):440-2 PMID: 3262202
  34. An improved rosetting assay for detection of human T lymphocytes.
    J Immunol Methods. 1974 Jul;5(2):131-5 PMID: 4600315
  35. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
    Nature. 1984 Jul 19-25;310(5974):207-11 PMID: 6087149
  36. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
    J Mol Appl Genet. 1982;1(4):327-41 PMID: 6286831
  37. Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells.
    Proc Natl Acad Sci U S A. 1983 May;80(9):2762-6 PMID: 6302703
  38. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.
    Cell. 1991 Jun 28;65(7):1107-15 PMID: 1648447
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1992-04-00
Pages
1899-906
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC288977
Subset
IM
Grants
NCI NIH HHS · CA4312203 · United States
NCRR NIH HHS · RR0564823 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]